These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 18946610

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Mycophenolate mofetil therapy in immunoglobulin A nephropathy: histological changes after treatment.
    Beckwith H, Medjeral-Thomas N, Galliford J, Griffith M, Levy J, Lightstone L, Palmer A, Roufosse C, Pusey C, Cook HT, Cairns T.
    Nephrol Dial Transplant; 2017 Jan 01; 32(suppl_1):i123-i128. PubMed ID: 28391339
    [Abstract] [Full Text] [Related]

  • 23. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC, Ying KY, Yim CW, Siu YP, Tong KH, To CH, Ng WL.
    Ann Rheum Dis; 2016 Jan 01; 75(1):30-6. PubMed ID: 25550339
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis.
    Du B, Jia Y, Zhou W, Min X, Miao L, Cui W.
    BMC Nephrol; 2017 Jul 19; 18(1):245. PubMed ID: 28724421
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide.
    Branten AJ, du Buf-Vereijken PW, Vervloet M, Wetzels JF.
    Am J Kidney Dis; 2007 Aug 19; 50(2):248-56. PubMed ID: 17660026
    [Abstract] [Full Text] [Related]

  • 27. A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616].
    Hogg RJ, Wyatt RJ, Scientific Planning Committee of the North American IgA Nephropathy Study.
    BMC Nephrol; 2004 Mar 25; 5():3. PubMed ID: 15043759
    [Abstract] [Full Text] [Related]

  • 28. Treatment of immunoglobulin A nephropathy.
    Schiele J, Nowack R, Julian BA, van der Woude FJ.
    Ann Med Interne (Paris); 1999 Feb 25; 150(2):127-36. PubMed ID: 10392261
    [Abstract] [Full Text] [Related]

  • 29. Delayed severe pneumonia in mycophenolate mofetil-treated patients with IgA nephropathy.
    Lv J, Zhang H, Cui Z, Su T, Zhang Y, Wang H.
    Nephrol Dial Transplant; 2008 Sep 25; 23(9):2868-72. PubMed ID: 18463325
    [Abstract] [Full Text] [Related]

  • 30. Mycophenolate mofetil treatment for therapy-resistant glomerulopathies.
    Sahin GM, Sahin S, Kantarci G, Ergin H.
    Nephrology (Carlton); 2007 Jun 25; 12(3):285-8. PubMed ID: 17498124
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of 'rescue therapy' with mycophenolate mofetil in resistant primary glomerulonephritis--a multicenter study.
    Segarra A, Amoedo ML, Martinez Garcia JM, Pons S, Praga M, Garcia EI, Alonso JC, Gascó JM, Pou L, Piera L.
    Nephrol Dial Transplant; 2007 May 25; 22(5):1351-60. PubMed ID: 17311833
    [Abstract] [Full Text] [Related]

  • 32. Low dose glucocorticoids, mycophenolate mofetil and hydroxychloroquine in IgA nephropathy, an update of current clinical trials.
    Chen P, Lv J.
    Nephrology (Carlton); 2024 Sep 25; 29 Suppl 2():25-29. PubMed ID: 39022897
    [Abstract] [Full Text] [Related]

  • 33. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W, Liu C, Xie H, Chen H, Liu Z, Li L.
    Nephrol Dial Transplant; 2008 Apr 25; 23(4):1307-12. PubMed ID: 18065810
    [Abstract] [Full Text] [Related]

  • 34. Low-Dose Corticosteroid Combined With Mycophenolate Mofetil for IgA Nephropathy With Stage 3 or 4 CKD: A Retrospective Cohort Study.
    Zhao J, Ma F, Bai M, Sun S.
    Clin Ther; 2021 May 25; 43(5):859-870. PubMed ID: 33863547
    [Abstract] [Full Text] [Related]

  • 35. The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.
    Choi JY, Kim DK, Kim YW, Yoo TH, Lee JP, Chung HC, Cho KH, An WS, Lee DH, Jung HY, Cho JH, Kim CD, Kim YL, Park SH.
    J Korean Med Sci; 2018 Feb 26; 33(9):e74. PubMed ID: 29441742
    [Abstract] [Full Text] [Related]

  • 36. Mycophenolate mofetil treatment of crescentic Henoch-Schönlein nephritis with IgA depositions.
    Dede F, Onec B, Ayli D, Gonul II, Onec K.
    Scand J Urol Nephrol; 2008 Feb 26; 42(2):178-80. PubMed ID: 17853044
    [Abstract] [Full Text] [Related]

  • 37. One-year angiotensin-converting enzyme inhibition plus mycophenolate mofetil immunosuppression in the course of early IgA nephropathy: a multicenter, randomised, controlled study.
    Dal Canton A, Amore A, Barbano G, Coppo R, Emma F, Grandaliano G, Klersy C, Perfumo F, Rizzoni G, Schena FP, Sepe V, Angiotensin Inhibition Mycophenolate mophetil IgA Nephropathy study investigators.
    J Nephrol; 2005 Feb 26; 18(2):136-40. PubMed ID: 15944996
    [Abstract] [Full Text] [Related]

  • 38. Treatment of severe IgA nephropathy: mycophenolate mofetil/prednisone compared to cyclophosphamide/prednisone.
    Liu X, Dewei D, Sun S, Xu G, Liu H, He L, Zhang P.
    Int J Clin Pharmacol Ther; 2014 Feb 26; 52(2):95-102. PubMed ID: 24161158
    [Abstract] [Full Text] [Related]

  • 39. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis with poor kidney function: a subgroup analysis of the Aspreva Lupus Management Study.
    Walsh M, Solomons N, Lisk L, Jayne DR.
    Am J Kidney Dis; 2013 May 26; 61(5):710-5. PubMed ID: 23375819
    [Abstract] [Full Text] [Related]

  • 40. Therapy of IgA nephropathy with mycophenolate mofetil--report of 3 cases.
    Bergner R, Hoffmann M, Brass H, Uppenkamp M.
    Clin Nephrol; 2004 Mar 26; 61(3):207-12. PubMed ID: 15077872
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.